FRANKFURT (Reuters) – Moderna will charge governments between $ 25 and $ 37 per dose from its candidate for the COVID-19 vaccine, depending on the amount ordered, CEO Stefan Bansel told the German weekly Welt am Sonntag (WamS).
“Therefore, our vaccine costs about the same as the flu vaccine, which is between $ 1
On Monday, an EU representative involved in the negotiations said the European Commission wanted to reach a deal with Moderna to supply millions of doses of its vaccine candidate at a price below $ 25 per dose.
“Nothing has been signed yet, but we are close to a deal with the EU commission. We want to deliver to Europe and we are negotiating constructively, “Bansel told WamS, adding that it was only a matter of” days “until the contract was ready.
Moderna said its experimental vaccine was 94.5% effective in preventing COVID-19 based on intermediate data from a late-stage clinical trial, becoming the second developer to report results that far exceeded expectations after Pfizer and its partner BioNTech.
The EU has been negotiating with Moderna for its experimental COVID-19 vaccine since at least July.
Report by Christoph Steitz; Edited by Mark Potter